Can Avacopan Replace Prednisone for GPA Treatment?
At a Glance
Avacopan (Tavneos) is a steroid-sparing medication for Granulomatosis with polyangiitis (GPA) that drastically reduces the need for long-term prednisone. While it helps avoid a prolonged steroid taper, patients often still need a short course of steroids initially to quickly control inflammation.
In this answer
4 sections
Avacopan (brand name Tavneos) is a significant advancement in treating severe active ANCA-associated vasculitis—specifically Granulomatosis with polyangiitis (GPA) and Microscopic polyangiitis (MPA)—that drastically reduces the need for prednisone [1][2]. However, it typically does not completely eliminate the need for steroids right away. Avacopan, which is an oral capsule taken twice daily, is known as a steroid-sparing medication, meaning it reduces the total amount of steroids you need over time [3][4]. While it allows patients to avoid the grueling long-term, high-dose prednisone taper, many people still require a brief, lower-dose course of steroids when they first start treatment to quickly calm the inflammation [5].
How Avacopan Changes Steroid Use
Historically, getting a GPA flare under control required taking high doses of prednisone for many months, followed by a slow taper. This approach is notorious for severe side effects like weight gain, bone loss, mood swings, and a higher risk of infection.
Avacopan works differently by directly targeting a specific part of the immune system that drives blood vessel inflammation [1]. In a major clinical trial called the ADVOCATE trial, researchers found that replacing the standard long-term prednisone taper with avacopan was just as effective at putting the disease into remission at 6 months [1]. Furthermore, patients taking avacopan were more likely to stay in remission at the one-year mark compared to those on the standard steroid taper [1]. Crucially, patients in the avacopan group experienced significantly less steroid-related toxicity [6][7].
When Might You Still Need Prednisone?
Even with avacopan in your treatment plan, you may still encounter situations where steroids are necessary:
- Initial Induction Therapy: When your disease is highly active, your doctor may prescribe a short course of steroids to quickly suppress the severe inflammation while avacopan and other medications take effect [3].
- Infusion Premedication: If you are receiving rituximab infusions alongside avacopan, you will likely be given a small dose of intravenous steroids right before the infusion to prevent an allergic reaction [5].
- Disease Flares: If your symptoms worsen unexpectedly, a short burst of steroids might be needed to regain control [3].
Understanding Avacopan’s Side Effects and Monitoring
While avacopan spares patients from many of the dreaded side effects of long-term prednisone, it is not without its own risks. Avacopan suppresses part of your immune system, which can increase the risk of serious infections [8].
Additionally, avacopan carries a risk of drug-induced liver toxicity [8][9]. Because of this, your doctor will require you to get regular blood tests to monitor your liver enzymes while you are taking the medication. If your liver enzymes become elevated, your doctor may need to adjust your dose or temporarily stop the medication.
Avacopan is a Team Player
It is important to understand that avacopan is not meant to be used by itself. It is an adjunctive therapy, meaning it is prescribed alongside other powerful immunosuppressant medications—most commonly rituximab or cyclophosphamide [10][11]. The combination of these medications works together to shut down the immune system’s attack on your blood vessels.
While avacopan may not be a 100% replacement for prednisone on day one, it successfully acts as a long-term replacement that spares patients from the most damaging, prolonged steroid side effects [6]. The duration of avacopan treatment varies; in clinical trials, patients typically took it for 52 weeks, but your rheumatologist will determine the best timeline for your specific situation [1].
Common questions in this guide
Can I stop taking prednisone completely if I start avacopan?
How does avacopan differ from a standard prednisone taper?
Do I take avacopan by itself to treat GPA?
What are the side effects of taking avacopan?
Why do I need regular blood tests while taking avacopan?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Am I a good candidate for adding avacopan to my treatment plan, given my current symptoms and organ involvement?
- 2.If I start avacopan, what exactly will my short-term steroid taper look like, and how quickly can I expect to be off prednisone completely?
- 3.How often will I need to have my blood drawn to check my liver function while taking avacopan?
- 4.What specific signs of infection should prompt me to call your office immediately while I am taking this medication?
- 5.Will I stay on avacopan long-term for maintenance therapy, or is it only used for the first year to achieve remission?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Avacopan for the Treatment of ANCA-Associated Vasculitis.
Jayne DRW, Merkel PA, Schall TJ, et al.
The New England journal of medicine 2021; (384(7)):599-609 doi:10.1056/NEJMoa2023386.
PMID: 33596356 - 2
The complement system in antineutrophil cytoplasmic antibody-associated vasculitis: pathogenic player and therapeutic target.
Mazzariol M, Manenti L, Vaglio A
Current opinion in rheumatology 2023; (35(1)):31-36 doi:10.1097/BOR.0000000000000914.
PMID: 36301247 - 3
Avacopan: First Approval.
Lee A
Drugs 2022; (82(1)):79-85 doi:10.1007/s40265-021-01643-6.
PMID: 34826105 - 4
The Glucocorticoid Toxicity Index-Metabolic Domains, an abridged version of the Glucocorticoid Toxicity Index: post-hoc analysis of data from the ADVOCATE trial.
Patel NJ, Jayne DRW, Merkel PA, et al.
The Lancet. Rheumatology 2023; (5(7)):e413-e421 doi:10.1016/S2665-9913(23)00131-5.
PMID: 38251552 - 5
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial.
Geetha D, Dua A, Yue H, et al.
Annals of the rheumatic diseases 2024; (83(2)):223-232 doi:10.1136/ard-2023-224816.
PMID: 37979959 - 6
Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial.
Geetha D, Pagnoux C, Sattui SE, et al.
Rheumatology (Oxford, England) 2025; (64(6)):3863-3871 doi:10.1093/rheumatology/keaf122.
PMID: 40037556 - 7
Treatment With Avacopan in ANCA-Associated Vasculitis With Kidney Involvement.
Geetha D, Cortazar FB, Bruchfeld A, et al.
Kidney international reports 2025; (10(8)):2751-2765 doi:10.1016/j.ekir.2025.05.041.
PMID: 40814647 - 8
Drug-induced liver injury due to avacopan improved by mycophenolate mofetil: A case report.
Yamashita R, Izumi Y, Takane K, et al.
Medicine 2025; (104(15)):e42121 doi:10.1097/MD.0000000000042121.
PMID: 40228281 - 9
Drug-induced liver injury related to avacopan therapy.
Mori K, Shirai T, Mutoh T, et al.
Rheumatology (Oxford, England) 2025; (64(5)):2533-2540 doi:10.1093/rheumatology/keae689.
PMID: 39672792 - 10
Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Merkel PA, Niles J, Jimenez R, et al.
ACR open rheumatology 2020; (2(11)):662-671 doi:10.1002/acr2.11185.
PMID: 33128347 - 11
Endobronchial Ulceration: A Different Manifestation of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.
Gonçalves AS, Menezes Freitas F, Sousa C, et al.
Cureus 2024; (16(6)):e62596 doi:10.7759/cureus.62596.
PMID: 39027740
This page provides educational information about avacopan and prednisone use for GPA. It does not replace professional medical advice. Always consult your rheumatologist before making any changes to your medication plan.
Get notified when new evidence is published on Granulomatosis with polyangiitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.